APO Research
Talk to an analyst

APO RESEARCH · REPORT

Marine Derived Drugs

Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydrophobic. These attributes make them fascinating compounds in terms of pharmacokinetics but also from a bioanalytical point of view.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydrophobic. These attributes make them fascinating compounds in terms of pharmacokinetics but also from a bioanalytical point of view.

The first marine-derived compound approved by the United States (US) Food and Drug Administration (FDA) was cytarabine (Cytosar U®) in 1969, followed by trabectedin (Yondelis®),eribulin mesylate (Halaven®), brentuximab vedotin (Adcetris®), and midostaurin (Rydapt®) in the years 2007, 2010, 2011, 2013, and 2017, respectively.

Selected research

Industry Growth & Trends

Global Marine Derived Drugs Industry Growth and Trends Forecast to 2032

21 December 202590 pages

Choose your research edition.

Industry ResearchMarine Derived Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Marine Derived Drugs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Marine Derived Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Marine Derived Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Marine Derived Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydrophobic. These attributes make them fascinating compounds in terms of pharmacokinetics but also from a bioanalytical point of view.

The first marine-derived compound approved by the United States (US) Food and Drug Administration (FDA) was cytarabine (Cytosar U®) in 1969, followed by trabectedin (Yondelis®),eribulin mesylate (Halaven®), brentuximab vedotin (Adcetris®), and midostaurin (Rydapt®) in the years 2007, 2010, 2011, 2013, and 2017, respectively.

Global Marine Derived Drugs key players include Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, etc. Global top five manufacturers hold a share about 85%.

Read the full market overview

North America is the largest market, with a share about 50%, followed by Europe and China, both have a share over 30 percent.

In terms of product, Mollusk is the largest segment, with a share about 50%. And in terms of application, the largest application is Antitumor Drugs, followed by Anti-Cardiovascular Drugs.

Report Scope

This report provides a structured, data-driven view of the global Marine Derived Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Marine Derived Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Marine Derived Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant toMarine Derived Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Marine Derived Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Marine Derived Drugs Market by Company

Seattle Genetics

Eisai Co

Tekada

Pfizer

Pharma Mar

Johnson and Johnson

GSK

TerSera Therapeutics

Teva

Marine Derived Drugs Segment by Type

Mollusk

Sponge

Tunicate

Fish

Others

Marine Derived Drugs Segment by Application

Antitumor Drugs

Anti-Cardiovascular Drugs

Others

Marine Derived Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marine Derived Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Marine Derived Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marine Derived Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Marine Derived Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Marine Derived Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Mollusk Table 2. Major Company of Sponge Table 3. Major Company of Tunicate Table 4. Major Company of Fish Table 5. Major Company of Others Table 6. Global Marine Derived Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Marine Derived Drugs Sales by Type (2021-2026) & (k units) Table 8. Global Marine Derived Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Marine Derived Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Marine Derived Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Marine Derived Drugs Price by Type (2021-2026) & (USD/unit) Table 12. Global Marine Derived Drugs Sales by Type (2027-2032) & (k units) Table 13. Global Marine Derived Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Marine Derived Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Marine Derived Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Marine Derived Drugs Price by Type (2027-2032) & (USD/unit) Table 17. North America Marine Derived Drugs Sales by Type (2021-2026) & (k units) Table 18. North America Marine Derived Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Marine Derived Drugs Sales by Type (2021-2026) & (k units) Table 20. Europe Marine Derived Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Marine Derived Drugs Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Marine Derived Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Marine Derived Drugs Sales by Type (2021-2026) & (k units) Table 24. Latin America Marine Derived Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Marine Derived Drugs Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Marine Derived Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Marine Derived Drugs Industry Trends Table 28. Marine Derived Drugs Industry Drivers Table 29. Marine Derived Drugs Industry Opportunities and Challenges Table 30. Marine Derived Drugs Industry Restraints Table 31. Global Marine Derived Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Marine Derived Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Marine Derived Drugs Sales by Company (2021-2026) & (k units) Table 34. Global Marine Derived Drugs Sales Share by Company (2021-2026) Table 35. Global Marine Derived Drugs Market Price by Company (2021-2026) & (USD/unit) Table 36. Global Marine Derived Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Marine Derived Drugs Major Company Production Sites and Headquarters Table 38. Global Marine Derived Drugs Company, Product Type & Application Table 39. Global Marine Derived Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Marine Derived Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Marine Derived Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Marine Derived Drugs Sales by Region (2021-2026) & (k units) Table 44. Global Marine Derived Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Marine Derived Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Marine Derived Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Marine Derived Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 48. Global Marine Derived Drugs Sales by Region (2027-2032) & (k units) Table 49. Global Marine Derived Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Marine Derived Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Marine Derived Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Marine Derived Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 53. Global Marine Derived Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Marine Derived Drugs Sales by Application (2021-2026) & (k units) Table 55. Global Marine Derived Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Marine Derived Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Marine Derived Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Marine Derived Drugs Price by Application (2021-2026) & (USD/unit) Table 59. Global Marine Derived Drugs Sales by Application (2027-2032) & (k units) Table 60. Global Marine Derived Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Marine Derived Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Marine Derived Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Marine Derived Drugs Price by Application (2027-2032) & (USD/unit) Table 64. North America Marine Derived Drugs Sales by Application (2021-2026) & (k units) Table 65. North America Marine Derived Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Marine Derived Drugs Sales by Application (2021-2026) & (k units) Table 67. Europe Marine Derived Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Marine Derived Drugs Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Marine Derived Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Marine Derived Drugs Sales by Application (2021-2026) & (k units) Table 71. Latin America Marine Derived Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Marine Derived Drugs Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Marine Derived Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Seattle Genetics Company Information Table 75. Seattle Genetics Business Overview Table 76. Seattle Genetics Marine Derived Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Seattle Genetics Marine Derived Drugs Product Portfolio Table 78. Seattle Genetics Recent Development Table 79. Eisai Co Company Information Table 80. Eisai Co Business Overview Table 81. Eisai Co Marine Derived Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Eisai Co Marine Derived Drugs Product Portfolio Table 83. Eisai Co Recent Development Table 84. Tekada Company Information Table 85. Tekada Business Overview Table 86. Tekada Marine Derived Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Tekada Marine Derived Drugs Product Portfolio Table 88. Tekada Recent Development Table 89. Pfizer Company Information Table 90. Pfizer Business Overview Table 91. Pfizer Marine Derived Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Pfizer Marine Derived Drugs Product Portfolio Table 93. Pfizer Recent Development Table 94. Pharma Mar Company Information Table 95. Pharma Mar Business Overview Table 96. Pharma Mar Marine Derived Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Pharma Mar Marine Derived Drugs Product Portfolio Table 98. Pharma Mar Recent Development Table 99. Johnson and Johnson Company Information Table 100. Johnson and Johnson Business Overview Table 101. Johnson and Johnson Marine Derived Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Johnson and Johnson Marine Derived Drugs Product Portfolio Table 103. Johnson and Johnson Recent Development Table 104. GSK Company Information Table 105. GSK Business Overview Table 106. GSK Marine Derived Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. GSK Marine Derived Drugs Product Portfolio Table 108. GSK Recent Development Table 109. TerSera Therapeutics Company Information Table 110. TerSera Therapeutics Business Overview Table 111. TerSera Therapeutics Marine Derived Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. TerSera Therapeutics Marine Derived Drugs Product Portfolio Table 113. TerSera Therapeutics Recent Development Table 114. Teva Company Information Table 115. Teva Business Overview Table 116. Teva Marine Derived Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Teva Marine Derived Drugs Product Portfolio Table 118. Teva Recent Development Table 119. North America Marine Derived Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 120. North America Marine Derived Drugs Sales by Country (2021-2026) & (k units) Table 121. North America Marine Derived Drugs Sales Market Share by Country (2021-2026) Table 122. North America Marine Derived Drugs Sales Forecast by Country (2027-2032) & (k units) Table 123. North America Marine Derived Drugs Sales Market Share Forecast by Country (2027-2032) Table 124. North America Marine Derived Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Marine Derived Drugs Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Marine Derived Drugs Market Share by Country (2021-2026) Table 127. North America Marine Derived Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Marine Derived Drugs Market Share Forecast by Country (2027-2032) Table 129. Europe Marine Derived Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. Europe Marine Derived Drugs Sales by Country (2021-2026) & (k units) Table 131. Europe Marine Derived Drugs Sales Market Share by Country (2021-2026) Table 132. Europe Marine Derived Drugs Sales Forecast by Country (2027-2032) & (k units) Table 133. Europe Marine Derived Drugs Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Marine Derived Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Marine Derived Drugs Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Marine Derived Drugs Market Share by Country (2021-2026) Table 137. Europe Marine Derived Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Marine Derived Drugs Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Marine Derived Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Marine Derived Drugs Sales by Country (2021-2026) & (k units) Table 141. Asia-Pacific Marine Derived Drugs Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Marine Derived Drugs Sales Forecast by Country (2027-2032) & (k units) Table 143. Asia-Pacific Marine Derived Drugs Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Marine Derived Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Marine Derived Drugs Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Marine Derived Drugs Market Share by Country (2021-2026) Table 147. Asia-Pacific Marine Derived Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Marine Derived Drugs Market Share Forecast by Country (2027-2032) Table 149. Latin America Marine Derived Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 150. Latin America Marine Derived Drugs Sales by Country (2021-2026) & (k units) Table 151. Latin America Marine Derived Drugs Sales Market Share by Country (2021-2026) Table 152. Latin America Marine Derived Drugs Sales Forecast by Country (2027-2032) & (k units) Table 153. Latin America Marine Derived Drugs Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Marine Derived Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Marine Derived Drugs Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Marine Derived Drugs Market Share by Country (2021-2026) Table 157. Latin America Marine Derived Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Marine Derived Drugs Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Marine Derived Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Marine Derived Drugs Sales by Country (2021-2026) & (k units) Table 161. Middle East and Africa Marine Derived Drugs Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Marine Derived Drugs Sales Forecast by Country (2027-2032) & (k units) Table 163. Middle East and Africa Marine Derived Drugs Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Marine Derived Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Marine Derived Drugs Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Marine Derived Drugs Market Share by Country (2021-2026) Table 167. Middle East and Africa Marine Derived Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Marine Derived Drugs Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Marine Derived Drugs Distributors List Table 172. Marine Derived Drugs Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Marine Derived Drugs Image Figure 2. Global Marine Derived Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Marine Derived Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Marine Derived Drugs Sales (2021-2032) & (k units) Figure 5. Mollusk Image Figure 6. Global Mollusk Sales YoY Growth (2021-2032) & (k units) Figure 7. Sponge Image Figure 8. Global Sponge Sales YoY Growth (2021-2032) & (k units) Figure 9. Tunicate Image Figure 10. Global Tunicate Sales YoY Growth (2021-2032) & (k units) Figure 11. Fish Image Figure 12. Global Fish Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Marine Derived Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Marine Derived Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Marine Derived Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Marine Derived Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Marine Derived Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Marine Derived Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Marine Derived Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Marine Derived Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Marine Derived Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Marine Derived Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Marine Derived Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Marine Derived Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Marine Derived Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Antitumor Drugs Image Figure 30. Global Antitumor Drugs Sales YoY Growth (2021-2032) & (k units) Figure 31. Anti-Cardiovascular Drugs Image Figure 32. Global Anti-Cardiovascular Drugs Sales YoY Growth (2021-2032) & (k units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Marine Derived Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Marine Derived Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Marine Derived Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Marine Derived Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Marine Derived Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Marine Derived Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Marine Derived Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Marine Derived Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Marine Derived Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Marine Derived Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Marine Derived Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Marine Derived Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Marine Derived Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Marine Derived Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Marine Derived Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Marine Derived Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Marine Derived Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Marine Derived Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Marine Derived Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Marine Derived Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Marine Derived Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Marine Derived Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Marine Derived Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Marine Derived Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Marine Derived Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Marine Derived Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Marine Derived Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Marine Derived Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Marine Derived Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Marine Derived Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Marine Derived Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Marine Derived Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Marine Derived Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Marine Derived Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Mollusk
  • Sponge
  • Tunicate
  • Fish
  • Others
Applications
  • Antitumor Drugs
  • Anti-Cardiovascular Drugs
  • Others
Companies covered
  • Seattle Genetics
  • Eisai Co
  • Tekada
  • Pfizer
  • Pharma Mar
  • Johnson and Johnson
  • GSK
  • TerSera Therapeutics
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Marine Derived Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Marine Derived Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Marine Derived Drugs Market by Type
  6. 1.3.1 Mollusk
  7. 1.3.2 Sponge
  8. 1.3.3 Tunicate
  9. 1.3.4 Fish
  10. 1.3.5 Others
  11. 1.4 Global Marine Derived Drugs Market Size by Type
  12. 1.4.1 Global Marine Derived Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Marine Derived Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Marine Derived Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Marine Derived Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Marine Derived Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Marine Derived Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Marine Derived Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Marine Derived Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Marine Derived Drugs Industry Trends
  2. 2.2 Marine Derived Drugs Industry Drivers
  3. 2.3 Marine Derived Drugs Industry Opportunities and Challenges
  4. 2.4 Marine Derived Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Marine Derived Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Marine Derived Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Marine Derived Drugs Price (2021-2026)
  4. 3.4 Global Marine Derived Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Marine Derived Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Marine Derived Drugs Company, Product Type & Application
  7. 3.7 Global Marine Derived Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Marine Derived Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Marine Derived Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Marine Derived Drugs Tier 1, Tier 2, and Tier 3
4 Marine Derived Drugs Regional Status and Outlook
  1. 4.1 Global Marine Derived Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Marine Derived Drugs Historic Market Size by Region
  3. 4.2.1 Global Marine Derived Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Marine Derived Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Marine Derived Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Marine Derived Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Marine Derived Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Marine Derived Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Marine Derived Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Marine Derived Drugs by Application
  1. 5.1 Marine Derived Drugs Market by Application
  2. 5.1.1 Antitumor Drugs
  3. 5.1.2 Anti-Cardiovascular Drugs
  4. 5.1.3 Others
  5. 5.2 Global Marine Derived Drugs Market Size by Application
  6. 5.2.1 Global Marine Derived Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Marine Derived Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Marine Derived Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Marine Derived Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Marine Derived Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Marine Derived Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Marine Derived Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Marine Derived Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Seattle Genetics
  2. 6.1.1 Seattle Genetics Company Information
  3. 6.1.2 Seattle Genetics Business Overview
  4. 6.1.3 Seattle Genetics Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Seattle Genetics Marine Derived Drugs Product Portfolio
  6. 6.1.5 Seattle Genetics Recent Developments
  7. 6.2 Eisai Co
  8. 6.2.1 Eisai Co Company Information
  9. 6.2.2 Eisai Co Business Overview
  10. 6.2.3 Eisai Co Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eisai Co Marine Derived Drugs Product Portfolio
  12. 6.2.5 Eisai Co Recent Developments
  13. 6.3 Tekada
  14. 6.3.1 Tekada Company Information
  15. 6.3.2 Tekada Business Overview
  16. 6.3.3 Tekada Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tekada Marine Derived Drugs Product Portfolio
  18. 6.3.5 Tekada Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Marine Derived Drugs Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Pharma Mar
  26. 6.5.1 Pharma Mar Company Information
  27. 6.5.2 Pharma Mar Business Overview
  28. 6.5.3 Pharma Mar Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pharma Mar Marine Derived Drugs Product Portfolio
  30. 6.5.5 Pharma Mar Recent Developments
  31. 6.6 Johnson and Johnson
  32. 6.6.1 Johnson and Johnson Company Information
  33. 6.6.2 Johnson and Johnson Business Overview
  34. 6.6.3 Johnson and Johnson Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Johnson and Johnson Marine Derived Drugs Product Portfolio
  36. 6.6.5 Johnson and Johnson Recent Developments
  37. 6.7 GSK
  38. 6.7.1 GSK Company Information
  39. 6.7.2 GSK Business Overview
  40. 6.7.3 GSK Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GSK Marine Derived Drugs Product Portfolio
  42. 6.7.5 GSK Recent Developments
  43. 6.8 TerSera Therapeutics
  44. 6.8.1 TerSera Therapeutics Company Information
  45. 6.8.2 TerSera Therapeutics Business Overview
  46. 6.8.3 TerSera Therapeutics Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 TerSera Therapeutics Marine Derived Drugs Product Portfolio
  48. 6.8.5 TerSera Therapeutics Recent Developments
  49. 6.9 Teva
  50. 6.9.1 Teva Company Information
  51. 6.9.2 Teva Business Overview
  52. 6.9.3 Teva Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Teva Marine Derived Drugs Product Portfolio
  54. 6.9.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Marine Derived Drugs Sales by Country
  2. 7.1.1 North America Marine Derived Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Marine Derived Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Marine Derived Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Marine Derived Drugs Market Size by Country
  6. 7.2.1 North America Marine Derived Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Marine Derived Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Marine Derived Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Marine Derived Drugs Sales by Country
  2. 8.1.1 Europe Marine Derived Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Marine Derived Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Marine Derived Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Marine Derived Drugs Market Size by Country
  6. 8.2.1 Europe Marine Derived Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Marine Derived Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Marine Derived Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Marine Derived Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Marine Derived Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Marine Derived Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Marine Derived Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Marine Derived Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Marine Derived Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Marine Derived Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Marine Derived Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Marine Derived Drugs Sales by Country
  2. 10.1.1 South America Marine Derived Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Marine Derived Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Marine Derived Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Marine Derived Drugs Market Size by Country
  6. 10.2.1 South America Marine Derived Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Marine Derived Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Marine Derived Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Marine Derived Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Marine Derived Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Marine Derived Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Marine Derived Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Marine Derived Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Marine Derived Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Marine Derived Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Marine Derived Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Marine Derived Drugs Value Chain Analysis
  2. 12.1.1 Marine Derived Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Marine Derived Drugs Production Mode & Process
  7. 12.2 Marine Derived Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Marine Derived Drugs Distributors
  10. 12.2.3 Marine Derived Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst